Plain-English translation of NCT06524830 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called VLS-01, which comes as a small dissolvable film you place in your mouth (like a breath strip). The study wants to see if VLS-01 can reduce depression symptoms in people who haven't gotten better from trying other antidepressants. About 142 people will participate in this research.
Many people with depression don't respond well to standard antidepressant pills, leaving them stuck without effective options. This medication is being tested to see if it offers hope for people whose depression has been hard to treat.
You likely qualify if…
You likely don't qualify if…
You would receive the medication (or placebo) as a small dissolvable film placed between your cheek and gum, twice over 2 weeks during the first part of the study. Your depression symptoms would be checked regularly over 12 weeks. After that, everyone gets a third dose of the medication (not placebo) and is monitored for another 2 weeks. In total, the study lasts about 3–4 months, with multiple clinic visits for symptom assessments and safety checks.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States